$ZYNE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Zynerba Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Zynerba Pharmaceuticals, Inc.. Get notifications about new insider transactions in Zynerba Pharmaceuticals, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 3.58 | 78,000 | 279,240 | 78,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 52,000 | 0 | 72,718 | 20.7 K to 72.7 K (+250.99 %) |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 3.58 | 161,867 | 579,484 | 161,867 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Grant | A | 0.00 | 107,911 | 0 | 460,423 | 352.5 K to 460.4 K (+30.61 %) |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Option Exercise | A | 3.58 | 110,000 | 393,800 | 110,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Grant | A | 0.00 | 75,000 | 0 | 261,146 | 186.1 K to 261.1 K (+40.29 %) |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Rosenberger Brian | VP, Commercial & Bu ... | Option Exercise | A | 3.58 | 55,000 | 196,900 | 55,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Rosenberger Brian | VP, Commercial & Bu ... | Grant | A | 0.00 | 37,000 | 0 | 37,000 | 0 to 37 K |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Option Exercise | A | 3.58 | 55,000 | 196,900 | 55,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Grant | A | 0.00 | 37,000 | 0 | 80,693 | 43.7 K to 80.7 K (+84.68 %) |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | COOPER WARREN D | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | Stephenson Pamela | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Feb 03 2020 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 5.05 | 162,480 | 820,524 | 162,480 | |
| Feb 03 2020 | ZYNE | Zynerba Pharmaceut ... | Rosenberger Brian | VP, Commercial & Bu ... | Option Exercise | A | 5.05 | 10,000 | 50,500 | 10,000 | |
| Feb 03 2020 | ZYNE | Zynerba Pharmaceut ... | Rosenberger Brian | VP, Commercial & Bu ... | Option Exercise | A | 5.05 | 48,000 | 242,400 | 48,000 | |
| Feb 03 2020 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Option Exercise | A | 5.05 | 60,000 | 303,000 | 60,000 | |
| Feb 03 2020 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Option Exercise | A | 5.05 | 120,000 | 606,000 | 120,000 | |
| Feb 03 2020 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 5.05 | 85,000 | 429,250 | 85,000 | |
| Jul 03 2019 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 14.11 | 666 | 9,397 | 666 | |
| Jun 13 2019 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
| Jun 13 2019 | ZYNE | Zynerba Pharmaceut ... | Stephenson Pamela | Director | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
| Jun 13 2019 | ZYNE | Zynerba Pharmaceut ... | COOPER WARREN D | Director | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
| Jun 13 2019 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
| Jun 13 2019 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
| Jun 13 2019 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
| Apr 03 2019 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 5.40 | 1,728 | 9,331 | 1,728 | |
| Feb 20 2019 | ZYNE | Zynerba Pharmaceut ... | Stephenson Pamela | Director | Option Exercise | A | 5.03 | 35,000 | 176,050 | 35,000 | |
| Jan 28 2019 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Option Exercise | A | 3.65 | 52,859 | 192,935 | 52,859 | |
| Jan 28 2019 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Option Exercise | A | 3.65 | 120,000 | 438,000 | 120,000 | |
| Jan 28 2019 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Grant | A | 0.00 | 3,600 | 0 | 186,146 | 182.5 K to 186.1 K (+1.97 %) |
| Jan 28 2019 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 3.65 | 160,000 | 584,000 | 160,000 | |
| Jan 28 2019 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 3.65 | 88,099 | 321,561 | 88,099 | |
| Jan 28 2019 | ZYNE | Zynerba Pharmaceut ... | Rosenberger Brian | VP, Commercial | Option Exercise | A | 3.65 | 42,287 | 154,348 | 42,287 | |
| Jan 04 2019 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 3.72 | 2,450 | 9,114 | 2,450 | |
| Oct 02 2018 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 7.86 | 1,334 | 10,485 | 1,334 | |
| Oct 02 2018 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 7.86 | 1,152 | 9,055 | 1,152 | |
| Aug 22 2018 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Buy | P | 6.43 | 5,000 | 32,153 | 5,000 | 0 to 5 K |
| Aug 07 2018 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Buy | P | 5.96 | 15,000 | 89,423 | 352,512 | 337.5 K to 352.5 K (+4.44 %) |
| Aug 07 2018 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Buy | P | 5.80 | 3,800 | 22,048 | 43,693 | 39.9 K to 43.7 K (+9.53 %) |
| Aug 07 2018 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Buy | P | 5.79 | 3,800 | 22,013 | 182,546 | 178.7 K to 182.5 K (+2.13 %) |
| Aug 07 2018 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 5.97 | 8,518 | 50,842 | 20,718 | 12.2 K to 20.7 K (+69.82 %) |
| Jul 03 2018 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 9.70 | 952 | 9,234 | 952 | |
| Jul 03 2018 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 9.70 | 1,103 | 10,699 | 1,103 | |
| Jun 07 2018 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 11.30 | 15,000 | 169,500 | 15,000 | |
| Jun 07 2018 | ZYNE | Zynerba Pharmaceut ... | HARRISON THOMAS L | Director | Option Exercise | A | 11.30 | 15,000 | 169,500 | 15,000 | |
| Jun 07 2018 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 11.30 | 15,000 | 169,500 | 15,000 | |
| Jun 07 2018 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 11.30 | 15,000 | 169,500 | 15,000 | |
| Jun 07 2018 | ZYNE | Zynerba Pharmaceut ... | COOPER WARREN D | Director | Option Exercise | A | 11.30 | 15,000 | 169,500 | 15,000 | |
| Jun 07 2018 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 11.30 | 15,000 | 169,500 | 15,000 | |
| May 31 2018 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Buy | P | 10.45 | 5,885 | 61,498 | 1,500,000 | 1.5 M to 1.5 M (+0.39 %) |
| May 02 2018 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Buy | P | 10.46 | 15,000 | 156,945 | 1,494,115 | 1.5 M to 1.5 M (+1.01 %) |
| Apr 16 2018 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 9.90 | 35,000 | 346,500 | 35,000 | |
| Apr 03 2018 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 7.98 | 1,161 | 9,265 | 1,161 | |
| Apr 03 2018 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 7.98 | 1,344 | 10,725 | 1,344 | |
| Mar 23 2018 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Buy | P | 9.28 | 10,000 | 92,790 | 1,479,115 | 1.5 M to 1.5 M (+0.68 %) |
| Jan 16 2018 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 11.71 | 67,500 | 790,425 | 67,500 | |
| Jan 16 2018 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, General Counse ... | Option Exercise | A | 11.71 | 42,700 | 500,017 | 42,700 | |
| Jan 16 2018 | ZYNE | Zynerba Pharmaceut ... | Rosenberger Brian | VP, Commercial | Option Exercise | A | 11.71 | 42,000 | 491,820 | 42,000 | |
| Jan 16 2018 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Option Exercise | A | 11.71 | 43,920 | 514,303 | 43,920 | |
| Jan 16 2018 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 11.71 | 81,000 | 948,510 | 81,000 | |
| Jan 04 2018 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 13.00 | 754 | 9,798 | 754 | |
| Jan 03 2018 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Buy | P | 12.99 | 15,000 | 194,847 | 1,469,115 | 1.5 M to 1.5 M (+1.03 %) |
| Oct 23 2017 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Buy | P | 9.94 | 25,745 | 255,795 | 1,454,115 | 1.4 M to 1.5 M (+1.80 %) |
| Oct 23 2017 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Buy | P | 9.78 | 30,000 | 293,538 | 1,428,370 | 1.4 M to 1.4 M (+2.15 %) |
| Oct 23 2017 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Buy | P | 9.59 | 44,255 | 424,405 | 1,398,370 | 1.4 M to 1.4 M (+3.27 %) |
| Oct 03 2017 | ZYNE | Zynerba Pharmaceut ... | HARRISON THOMAS L | Director | Option Exercise | A | 8.69 | 2,057 | 17,875 | 2,057 | |
| Oct 03 2017 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 8.69 | 971 | 8,438 | 971 | |
| Oct 03 2017 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 8.69 | 1,714 | 14,895 | 1,714 | |
| Jul 06 2017 | ZYNE | Zynerba Pharmaceut ... | Rask Cynthia Ann | Director | Option Exercise | A | 16.90 | 511 | 8,636 | 511 | |
| Jul 06 2017 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 16.90 | 500 | 8,450 | 500 | |
| Jul 06 2017 | ZYNE | Zynerba Pharmaceut ... | HARRISON THOMAS L | Director | Option Exercise | A | 16.90 | 1,058 | 17,880 | 1,058 | |
| Jul 06 2017 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 16.90 | 882 | 14,906 | 882 | |
| Jun 09 2017 | ZYNE | Zynerba Pharmaceut ... | Rask Cynthia Ann | Director | Option Exercise | A | 18.77 | 15,000 | 281,550 | 15,000 | |
| Jun 09 2017 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 18.77 | 15,000 | 281,550 | 15,000 | |
| Jun 09 2017 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 18.77 | 15,000 | 281,550 | 15,000 | |
| Jun 09 2017 | ZYNE | Zynerba Pharmaceut ... | HARRISON THOMAS L | Director | Option Exercise | A | 18.77 | 15,000 | 281,550 | 15,000 | |
| Jun 09 2017 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 18.77 | 15,000 | 281,550 | 15,000 | |
| Jun 09 2017 | ZYNE | Zynerba Pharmaceut ... | COOPER WARREN D | Director | Option Exercise | A | 18.77 | 15,000 | 281,550 | 15,000 | |
| May 16 2017 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Buy | P | 19.57 | 1,500 | 29,355 | 337,512 | 336 K to 337.5 K (+0.45 %) |
| May 16 2017 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Buy | P | 19.76 | 3,500 | 69,160 | 336,012 | 332.5 K to 336 K (+1.05 %) |
| May 16 2017 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 19.82 | 5,200 | 103,064 | 12,200 | 7 K to 12.2 K (+74.29 %) |
| Apr 04 2017 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 20.32 | 734 | 14,915 | 734 | |
| Jan 26 2017 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Option Exercise | A | 18.22 | 75,000 | 1,366,500 | 75,000 | |
| Jan 26 2017 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, General Counse ... | Option Exercise | A | 18.22 | 60,000 | 1,093,200 | 60,000 | |
| Jan 26 2017 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 18.22 | 31,350 | 571,197 | 31,350 | |
| Jan 26 2017 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 18.22 | 125,000 | 2,277,500 | 125,000 | |
| Jan 25 2017 | ZYNE | Zynerba Pharmaceut ... | Rosenberger Brian | VP, Commercial | Option Exercise | A | 22.46 | 37,500 | 842,250 | 37,500 | |
| Dec 29 2016 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Buy | P | 15.85 | 10,000 | 158,500 | 1,354,115 | 1.3 M to 1.4 M (+0.74 %) |
| Dec 08 2016 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 14.03 | 4,000 | 56,120 | 7,000 | 3 K to 7 K (+133.33 %) |
| Dec 08 2016 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 14.15 | 3,000 | 42,450 | 3,000 | 0 to 3 K |
| Sep 22 2016 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 10.23 | 150,000 | 1,534,500 | 150,000 | |
| Aug 17 2016 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, General Counse ... | Sell | S | 10.53 | 3,000 | 31,590 | 0 | 3 K to 0 (-100.00 %) |
| Aug 17 2016 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, General Counse ... | Buy | P | 17.92 | 3,000 | 53,760 | 3,000 | 0 to 3 K |
| Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | Rask Cynthia Ann | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
| Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
| Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
| Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | HARRISON THOMAS L | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
| Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
| Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | COOPER WARREN D | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
| Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | HARRISON THOMAS L | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
| Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
| Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | COOPER WARREN D | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
| Feb 16 2016 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Buy | J | 0.00 | 80,467 | 0 | 1,344,115 | 1.3 M to 1.3 M (+6.37 %) |
| Sep 15 2015 | ZYNE | Zynerba Pharmaceut ... | BARON RICHARD A | Chief Financial Off ... | Option Exercise | M | 3.98 | 15,957 | 63,509 | 47,872 | |
| Sep 15 2015 | ZYNE | Zynerba Pharmaceut ... | BARON RICHARD A | Chief Financial Off ... | Buy | M | 3.98 | 15,957 | 63,509 | 15,957 | 0 to 16 K |
| Aug 12 2015 | ZYNE | Zynerba Pharmaceut ... | HARRISON THOMAS L | Director | Buy | P | 14.00 | 12,500 | 175,000 | 12,500 | 0 to 12.5 K |
| Aug 10 2015 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
| Aug 10 2015 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| Aug 10 2015 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Buy | C | 0.00 | 13,297 | 0 | 13,297 | 0 to 13.3 K |
| Aug 10 2015 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Buy | C | 0.00 | 26,595 | 0 | 26,595 | 0 to 26.6 K |
| Aug 10 2015 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Option Exercise | C | 0.00 | 1,066,911 | 0 | 0 | |
| Aug 10 2015 | ZYNE | Zynerba Pharmaceut ... | RAPP MICHAEL | 10% Owner | Buy | C | 0.00 | 567,505 | 0 | 1,263,648 | 696.1 K to 1.3 M (+81.52 %) |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 14.00 | 396,678 | 5,553,492 | 396,678 | |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | BARON RICHARD A | Chief Financial Off ... | Option Exercise | A | 14.00 | 75,988 | 1,063,832 | 75,988 | |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 14.00 | 35,000 | 490,000 | 35,000 | |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | COOPER WARREN D | Director | Option Exercise | A | 14.00 | 35,000 | 490,000 | 35,000 | |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | Rask Cynthia Ann | Director | Option Exercise | A | 14.00 | 35,000 | 490,000 | 35,000 | |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 14.00 | 35,000 | 490,000 | 35,000 | |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | HARRISON THOMAS L | Director | Option Exercise | A | 14.00 | 35,000 | 490,000 | 35,000 | |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 14.00 | 35,000 | 490,000 | 35,000 | |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Option Exercise | A | 14.00 | 201,981 | 2,827,734 | 201,981 | |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | General Counsel | Option Exercise | A | 14.00 | 46,616 | 652,624 | 46,616 |
Page: 1